These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 31235653)

  • 1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.
    Antonioli L; Blandizzi C; Pacher P; Haskó G
    Pharmacol Rev; 2019 Jul; 71(3):345-382. PubMed ID: 31235653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling Chronic Pain and Inflammation through the Purinergic System.
    Magni G; Riccio D; Ceruti S
    Curr Med Chem; 2018; 25(32):3830-3865. PubMed ID: 28699505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches for designing and discovering purinergic drugs for gastrointestinal diseases.
    Dal Ben D; Antonioli L; Lambertucci C; Spinaci A; Fornai M; D'Antongiovanni V; Pellegrini C; Blandizzi C; Volpini R
    Expert Opin Drug Discov; 2020 Jun; 15(6):687-703. PubMed ID: 32228110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications.
    Tilley S; Volmer J; Picher M
    Subcell Biochem; 2011; 55():235-76. PubMed ID: 21560050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinoceptors in inflammation: potential as anti-inflammatory therapeutic targets.
    Ferrero ME
    Front Biosci (Landmark Ed); 2011 Jun; 16(6):2172-86. PubMed ID: 21622169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signalling in host innate immune defence against intracellular pathogens.
    Coutinho-Silva R; Savio LEB
    Biochem Pharmacol; 2021 May; 187():114405. PubMed ID: 33406411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
    Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X
    Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils and Purinergic Signaling in Health and Disease.
    Ferrari D; Vuerich M; Casciano F; Longhi MS; Melloni E; Secchiero P; Zech A; Robson SC; Müller T; Idzko M
    Front Immunol; 2020; 11():1339. PubMed ID: 32733449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillaries communicate with the arteriolar microvascular network by a pannexin/purinergic-dependent pathway in hamster skeletal muscle.
    Lamb IR; Novielli-Kuntz NM; Murrant CL
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1699-H1711. PubMed ID: 33606585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Gut Inflammation by Modulation of Purinergic Signaling.
    Vuerich M; Mukherjee S; Robson SC; Longhi MS
    Front Immunol; 2020; 11():1882. PubMed ID: 33072065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of purinergic signaling during gastrointestinal inflammation.
    Roberts JA; Lukewich MK; Sharkey KA; Furness JB; Mawe GM; Lomax AE
    Curr Opin Pharmacol; 2012 Dec; 12(6):659-66. PubMed ID: 23063457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine release.
    McIlvain HB; Ma L; Ludwig B; Manners MT; Martone RL; Dunlop J; Kaftan EJ; Kennedy JD; Whiteside GT
    Eur J Pharmacol; 2010 Sep; 643(2-3):202-10. PubMed ID: 20621081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Signaling and its Role in the Stem Cell Differentiation.
    Zaib S; Areeba ; Khan I
    Mini Rev Med Chem; 2024; 24(8):863-883. PubMed ID: 37828668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to the Special Issue on Purinergic Receptors.
    Burnstock G
    Adv Exp Med Biol; 2017; 1051():1-6. PubMed ID: 28224484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signaling in healthy and diseased skin.
    Burnstock G; Knight GE; Greig AV
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):526-46. PubMed ID: 22158558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights into how purines regulate pituitary cell function.
    Rees DA; Scanlon MF; Ham J
    Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
    Volonté C; D'Ambrosi N
    FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic Receptors Crosstalk with CCR5 to Amplify Ca
    Horioka M; Ceraudo E; Lorenzen E; Sakmar TP; Huber T
    Cell Mol Neurobiol; 2021 Jul; 41(5):1085-1101. PubMed ID: 33216235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases.
    Andrejew R; Glaser T; Oliveira-Giacomelli Á; Ribeiro D; Godoy M; Granato A; Ulrich H
    Adv Exp Med Biol; 2019; 1201():275-353. PubMed ID: 31898792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.